Skip to main content

Polio Vaccine – Novel Oral (nOPV) Monovalent type 2

Polio Vaccine – Novel Oral (nOPV) Monovalent type 2

 


Product Overview
 

    
Vaccine Type: Polio Vaccine - Novel Oral (nOPV) Monovalent type 2    

Commercial Name:
 		 PT BioFarma (Persero)    

Country:
 		 Indonesia    
URL:

http://www.biofarma.co.id/

    

Responsible NRA:

 National Agency of Drug and Food Control Indonesia    

Country:
 		 Indonesia    

URL:
 

http://www.pom.go.id/

    
 


WHO Recommendation
 

    
Effective date:
13 November 2020
 		    
 


Product Description
 

    
Pharmaceutical Form:
Liquid: ready to use
 		    
Presentation:
Vial
 		    
Number of doses:
50 doses
 		    
Route of administration:
Oral
 		    
Shelf-life:
24 months
 		 at storage temperature:  -20°C
Shell-life 6 months at storage temperature:   2-8°C
Vaccine Vial Monitor:
Type 2
 		    
Secondary Packaging:
Carton holds ten 50 doses vials [Dimensions: 11.5 x 4.7 x 5.1 cm.]
 		    
Tertiary Packaging:
Box holds 147 cartons (1470 vials / 73500 doses total)
[Dimensions: 65 x 51 x 60 cm]
 		    
Cold Chain Volume:
0.55
 		 cm3 (in secondary packaging)  
Preservative:
None
 


With concentration:                                 

Not applicable                           
Handling of opened multi-dose vials: WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.